US Patent Granted To Chrono Therapeutics Inc. For Its Chrono-Pharmacological Drug Delivery Systems And Applications.
Patent Protection extends at least to 2025
Release Date: 6/2/2010
Download The PDF
Chrono Therapeutics Inc. receives notification from the European Patent Office that an additional key patent for CHRONODOSE™ has been granted. This new patent grant affirms the novelty of CTI’s technology and believes it will considerably reduce any potential risk to the CTI group.
Chrono Therapeutics Inc. is featured in Transdermal Magazine.
(SEE PAGE 6)
Career Opportunities
Chrono Therapeutics Inc. Puts Patients First
Our primary mission is to improve the quality of life of everyday people in a tangible way.
We are working our hardest to revolutionize transdermal drug delivery through patient-tailored optimization. We seek to keep families together longer, help children fulfill there potential, improve the quality of life for the elderly, and move patients towards healthier and happier lives.
We seek the brightest, most well-accomplished scientists and professionals to assist us to bring next-generation drug products to market rapidly.
Guy DiPierro, CEO and Founder stated, “We continue to build a team that is motivated not only by monetary compensation, but also through the visceral understanding that our efforts really can improve health and extend life for millions. To this end we must work tirelessly to make our drug products available to the public.”
E-mail us your resume: info@chronodose.com